US stocks rose Wednesday after drugmaker Moderna announced an early coronavirus vaccine trial produced antibodies in all participants. Major indexes were also lifted by strong quarterly earnings from Goldman Sachs, which saw the firm handily beat analyst profit estimates. The so-called reopening trade gained, while oil climbed ahead of a key meeting between OPEC and its allies.
Dow rallies 300 points on positive vaccine-trial data, blockbuster Goldman earnings
Business Insider - 15 Jul 2020 15:43
US stocks rose Wednesday after drugmaker Moderna announced an early coronavirus vaccine trial produced antibodies in all participants. Major indexes were also lifted by strong quarterly earnings from Goldman Sachs, which saw the firm handily beat analyst profit estimates. The so-called reopening trade gained, while oil climbed ahead of a key meeting between OPEC and its allies.
Share this Article
Comment on this Article
Recommended
Please to comment